1. Home
  2. SAIC vs ELVN Comparison

SAIC vs ELVN Comparison

Compare SAIC & ELVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SCIENCE APPLICATIONS INTERNATIONAL CORPORATION

SAIC

SCIENCE APPLICATIONS INTERNATIONAL CORPORATION

N/A

Current Price

$125.82

Market Cap

4.5B

Sector

Technology

ML Signal

N/A

Logo Enliven Therapeutics Inc.

ELVN

Enliven Therapeutics Inc.

N/A

Current Price

$57.50

Market Cap

4.2B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
SAIC
ELVN
Founded
1969
2016
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.5B
4.2B
IPO Year
2013
2020

Fundamental Metrics

Financial Performance
Metric
SAIC
ELVN
Price
$125.82
$57.50
Analyst Decision
Hold
Strong Buy
Analyst Count
8
5
Target Price
$110.50
$43.40
AVG Volume (30 Days)
374.5K
986.1K
Earning Date
06-01-2026
05-11-2026
Dividend Yield
1.56%
N/A
EPS Growth
7.39
3.17
EPS
2.61
N/A
Revenue
$7,262,000,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$1.65
N/A
P/E Ratio
$49.31
N/A
Revenue Growth
N/A
N/A
52 Week Low
$81.08
$14.79
52 Week High
$129.70
$62.32

Technical Indicators

Market Signals
Indicator
SAIC
ELVN
Relative Strength Index (RSI) 68.33 59.86
Support Level $90.75 $25.63
Resistance Level N/A $62.32
Average True Range (ATR) 3.29 2.69
MACD 0.19 -0.29
Stochastic Oscillator 94.08 63.03

Price Performance

Historical Comparison
SAIC
ELVN

About SAIC SCIENCE APPLICATIONS INTERNATIONAL CORPORATION

Science Applications International Corp provides technical, engineering, and enterprise IT services mainly to the U.S. government. Specifically, it offers end-to-end solutions spanning the design, development, integration, deployment, management, operations, sustainment, and security of the customer's entire IT infrastructure. The company has two reportable segments, which include Defense and Intelligence and the Civilian segment. Maximum revenue is generated from its Defense and Intelligence segment, which provides a diverse portfolio of national security solutions to the DoW and the Intelligence Community of the United States Government. The Civilian segment provides solutions to the civilian markets, encompassing federal, state, and local governments.

About ELVN Enliven Therapeutics Inc.

Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics. The product candidates of the company include ELVN-001 is designed to specifically target the BCR-ABL fusion gene product, the oncogenic driver for patients with chronic myeloid leukemia (CML), ELVN-002 is designed to inhibit wild-type HER2 and key mutations of HER2.

Share on Social Networks: